Novavax | NVAX - Ordinary Share Capital


Novavax reported $1.62M in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
Adma Biologics USD 236.62M 242K Dec/2024
Agenus USD 266K 30K Mar/2025
AstraZeneca USD 1.55B 206K Dec/2025
BioCryst Pharmaceuticals USD 1.9M 3K Sep/2023
Cassava Sciences USD 48.31M 48.26M Sep/2025
Geron USD 638.36M 338K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
MannKind USD 307.83M 806K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Moderna USD 391M 2M Sep/2025
Novartis USD 1.92B 17.06M Sep/2025
Novavax USD 1.62M 211K Sep/2024
Pfizer USD 5.69B 1000K Sep/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025